BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15290165)

  • 1. Second-trimester genetic amniocentesis: 5-year experience.
    Turhan NO; Eren U; Seçkin NC
    Arch Gynecol Obstet; 2005 Jan; 271(1):19-21. PubMed ID: 15290165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-operator comparison of early and mid-second-trimester amniocentesis.
    Assel BG; Lewis SM; Dickerman LH; Park VM; Jassani MN
    Obstet Gynecol; 1992 Jun; 79(6):940-4. PubMed ID: 1579318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
    Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C
    J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.
    Cleary-Goldman J; Morgan MA; Malone FD; Robinson JN; D'Alton ME; Schulkin J
    Obstet Gynecol; 2006 Jan; 107(1):11-7. PubMed ID: 16394034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004.
    Tseng JJ; Chou MM; Lo FC; Lai HY; Chen MH; Ho ES
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):39-41. PubMed ID: 17272206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early amniocentesis.
    Henry GP; Miller WA
    J Reprod Med; 1992 May; 37(5):396-402. PubMed ID: 1507188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single physician's experience with four thousand six hundred genetic amniocenteses.
    Horger EO; Finch H; Vincent VA
    Am J Obstet Gynecol; 2001 Aug; 185(2):279-88. PubMed ID: 11518880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniocentesis in the third trimester of pregnancy.
    O'Donoghue K; Giorgi L; Pontello V; Pasquini L; Kumar S
    Prenat Diagn; 2007 Nov; 27(11):1000-4. PubMed ID: 17636852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic results of amniocentesis materials: incidence of abnormal karyotypes in the Turkish collaborative study.
    Karaoguz MY; Bal F; Yakut T; Ercelen NO; Ergun MA; Gokcen AB; Biri AA; Kimya Y; Urman B; Gultomruk M; Egeli U; Menevse S
    Genet Couns; 2006; 17(2):219-30. PubMed ID: 16970041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening.
    Towner D; Currier RJ; Lorey FW; Cunningham GC; Greve LC
    Am J Obstet Gynecol; 2007 Jun; 196(6):608.e1-5; discussion 608.e5. PubMed ID: 17547917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of congenital anomalies at birth among offspring of women at risk for a genetic disorder and with a normal second-trimester ultrasound.
    Lemyre E; Infante-Rivard C; Dallaire L
    Teratology; 1999 Oct; 60(4):240-4. PubMed ID: 10508977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorionic villus sampling for early prenatal diagnosis at Bhumibol Adulyadej Hospital.
    Rueangchainikhom W; Sarapak S; Orungrote N
    J Med Assoc Thai; 2008 Jan; 91(1):1-6. PubMed ID: 18386536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.